An aberrant increase of CDK7 levels has been detected in many different cancer types, e.g., gastric, pancreatic, colorectal and breast cancer, and often correlates with aggressiveness and poor prognosis [20,21,22,23]. The gene discussed is CDK7; the disease is cancer.